REQUEST A DEMO
Total
USD $0.00
Search more companies

Dhanvanthri Speciality Pharma Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Dhanvanthri Speciality Pharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dhanvanthri Speciality Pharma Private Limited is an unlisted company, incorporated on 31/03/2015. It has its registered office in the State of Karnataka, India. Company's corporate identification number (CIN) is U24100KA2015PTC079594 and registration number is 079594. The company is a trade company, it is engaged in wholesale trading.

Legal Address
No. 39/2, 2 Cross, 1St Main, C.K.C Garden, Mission Road Cross,
Bangalore; Karnataka; Postal Code: 560027

Contact Details: Purchase the Dhanvanthri Speciality Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Dhanvanthri Speciality Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Dhanvanthri Speciality Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Dhanvanthri Speciality Pharma Private Limited report to view the information.
Incorporation Date:
March 31, 2015
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Dhanvanthri Speciality Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
19.69%
Total operating revenue
19.69%
Operating profit (EBIT)
11.26%
EBITDA
15.01%
Net Profit (Loss) for the Period
11.69%
Total assets
5.53%
Total equity
29.54%
Operating Profit Margin (ROS)
-0.23%
Net Profit Margin
-0.16%
Return on Equity (ROE)
-3.65%
Debt to Equity Ratio
-29.71%
Quick Ratio
0.3%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?